WallStreetZenWallStreetZen

NASDAQ: EOLS
Evolus Inc Stock Ownership - Who owns Evolus?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Evolus Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Sandra BeaverChief Financial Officer2024-09-063,276$14.98
$49.07kSell
Tomoko YamagishidresslerChief Marketing Officer2024-08-305,631$15.85
$89.25kSell
David MoatazediCEO and President2024-06-06175,940$12.59
$2.21MSell
David MoatazediCEO and President2024-06-06175,940$7.28
$1.28MBuy
David MoatazediCEO and President2024-06-05155,278$5.46
$847.82kBuy
David MoatazediCEO and President2024-06-05155,278$12.92
$2.01MSell
David MoatazediCEO and President2024-06-04140,214$12.73
$1.78MSell
Vikram MalikDirector2024-06-037,500$12.96
$97.20kSell
David N. GillDirector2024-05-146,718$12.60
$84.65kSell
David N. GillDirector2024-05-133,643$12.73
$46.36kSell

1 of 3

EOLS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EOLS insiders and whales buy or sell their stock.

EOLS Shareholders

What type of owners hold Evolus Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Medytox Inc16.80%10,640,826$137.91MInsider
Perceptive Advisors LLC8.46%5,356,622$69.42MInstitution
Tang Capital Management LLC7.66%4,847,399$62.82MInstitution
Blackrock Inc 16.68%4,230,149$54.82MInstitution
Alphaeon 1 LLC6.66%4,214,871$54.62MInsider
Vanguard Group Inc5.05%3,195,331$41.41MInstitution
Nantahala Capital Management LLC4.46%2,824,849$36.61MInstitution
Caligan Partners LP3.46%2,193,488$28.43MInstitution
Stonepine Capital Management LLC2.16%1,369,821$17.75MInstitution
State Street Corp2.02%1,277,841$16.56MInstitution

1 of 3

EOLS vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EOLS73.92%26.08%Net Selling
CRON10.89%48.36%Net Selling
PCRX69.43%30.57%Net SellingNet Selling
PAHC44.51%55.49%Net Buying
BIOA57.66%24.77%Net BuyingNet Buying
View Top Pharmaceutical Stocks

Evolus Stock Ownership FAQ

Who owns Evolus?

Evolus (NASDAQ: EOLS) is owned by 79.43% institutional shareholders, 28.02% Evolus insiders, and 0.00% retail investors. Medytox Inc is the largest individual Evolus shareholder, owning 10.64M shares representing 16.80% of the company. Medytox Inc's Evolus shares are currently valued at $135.03M.

If you're new to stock investing, here's how to buy Evolus stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.